CB2

The CB2 receptor (cannabinoid receptor type 2) is one of two primary receptors in the endocannabinoid system — the other being CB1. Where CB1 is concentrated in the brain and is responsible for the intoxicating effects of cannabis, CB2 is found mostly in immune tissues: the spleen, tonsils, bone marrow, and circulating immune cells.

It is a G protein-coupled receptor, meaning it sits in the cell membrane and triggers intracellular signalling cascades when activated. CB2 expression in the central nervous system is comparatively low under normal conditions, though it increases in microglia and other immune-adjacent brain cells during inflammation or injury.

How it works · its role

When a cannabinoid binds to CB2, the receptor suppresses the production of pro-inflammatory signalling molecules and modulates how immune cells migrate and respond to tissue damage. The effect is broadly anti-inflammatory and immunomodulatory rather than psychoactive.

The body's own cannabinoid molecules — primarily 2-arachidonoylglycerol (2-AG) and, to a lesser extent, anandamide — activate CB2 as part of normal immune regulation. The system appears to act as a brake on excessive immune responses, helping to limit inflammation after injury or infection.

Because CB2 is so peripheral to the brain's intoxication circuits, its activation is thought to produce no noticeable subjective high. This makes it a target of interest in pharmaceutical research: selectively activating CB2 could in principle reduce pain and inflammation without the cognitive or perceptual effects associated with CB1 activation.

Relevance to substances & effects

Cannabis is the most familiar source of CB2-active compounds. THC, the primary intoxicant, binds both CB1 and CB2; its anti-inflammatory and analgesic properties are at least partly attributed to CB2 engagement. Cannabidiol (CBD) has a more complex relationship with the receptor — its affinity is low, but it may influence CB2 signalling indirectly through several mechanisms.

Beta-caryophyllene, a terpene found in cannabis and in many other plants including black pepper and cloves, is notable for being a selective CB2 agonist. It produces no intoxication and is the subject of ongoing research into inflammation and pain.

Synthetic CB2-selective agonists are under investigation for conditions involving chronic inflammation, neuropathic pain, and immune dysregulation. Because they aim to avoid CB1-mediated psychoactivity, they would not appear in discussions of recreational drug effects — their relevance to Psychedex is mainly in explaining why some cannabis effects (particularly analgesic and anti-inflammatory ones) occur without a proportional change in perception or intoxication.